[Tacrolimus-induced gynecomastia in a patient with polymyositis]

Med Clin (Barc). 2016 Mar 18;146(6):284-5. doi: 10.1016/j.medcli.2015.10.012. Epub 2015 Dec 8.

[Article in Spanish]

Authors

María Mar Muñoz Gómez¹, Eva Montané², Ana Lucía Arellano², Alejandro Olivé³

Affiliations

¹ Servicio de Reumatología, Hospital Universitario San Cecilio, Granada, España. Electronic address: mari936@hotmail.com.
² Servicio de Farmacología Clínica, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, España.
³ Servicio de Reumatología, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, España.

PMID: 26678165
DOI: 10.1016/j.medcli.2015.10.012

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Azathioprine / adverse effects
Azathioprine / therapeutic use
Drug Substitution
Drug Therapy, Combination
Gynecomastia / chemically induced*
Humans
Immunosuppressive Agents / adverse effects*
Immunosuppressive Agents / therapeutic use
Lung Diseases, Interstitial / chemically induced
Male
Methylprednisolone / therapeutic use
Middle Aged
Polymyositis / drug therapy*
Prednisone / therapeutic use
Tacrolimus / adverse effects*
Tacrolimus / therapeutic use

Substances

Immunosuppressive Agents
Azathioprine
Prednisone
Tacrolimus
Methylprednisolone